Medical Device News Magazine

New Non-Contact Forehead Infrared Thermometer to Aid in Coronavirus Prevention

About Medical Device News Magazine

About Medical Device News Magazine. We are a digital publication founded in 2008 located in the United States.

Advertise with Medical Device News Magazine! Join Our #1 Family of Advertisers!

We pride ourselves on being the best-kept secret when it comes to distributing your news! Our unique digital approach enables us to circulate your...

DeltaTrak reports the new Model 15004 Non-Contact Forehead Infrared Thermometer serves as a valuable solution in the fight against the Coronavirus. One of the first steps in preventing cross-contamination is to measure and screen personnel that may have a fever, which is one of the main symptoms of COVID-19.

The need to screen individuals that work together in large workforce environments is imperative to reduce the risk of spreading the infection. The new FDA and CE approved Forehead Infrared Thermometer provides instant readings without necessary contact making it an ideal COVID-19 risk prevention solution.

With so much concern about health and safety at this time, it was important that we provided a solution that can be used to quickly and safely measure body temperature in large group settings,” said Frederick Wu, President and CEO of DeltaTrak. “Our focus is presenting meaningful solutions to current pandemic conditions for businesses we serve around the world. We believe that this new non-contact forehead infrared thermometer will be significantly beneficial in performing the daily preventive protection measures that we must do to minimize cross-contamination and maximize safety for all of us in every community during this trying time.”

 

Medical Device News Magazinehttps://infomeddnews.com
Medical Device News Magazine provides breaking medical device / biotechnology news. Our subscribers include medical specialists, device industry executives, investors, and other allied health professionals, as well as patients who are interested in researching various medical devices. We hope you find value in our easy-to-read publication and its overall objectives! Medical Device News Magazine is a division of PTM Healthcare Marketing, Inc. Pauline T. Mayer is the managing editor.

Other News

Shoulder Innovations Further Strengthens IP Portfolio in Key Areas with Recent Patent Grants

"These recent grants further strengthen key patent families that are foundational to our technology, and we are pleased the USPTO continues to recognize our meaningful innovation in the shoulder arthroplasty segment," said Rob Ball, CEO of Shoulder Innovations. "This noteworthy expansion of our IP position represents the culmination of over 10 years of research and development, and we are proud of our team for their continued dedication to creating practical solutions for shoulder surgeons and advancing patient outcomes."

Radical Catheter Technologies Presents Analysis of Disruptive, Recently FDA-Cleared Endovascular Technology at the Society of NeuroInterventional Surgery 21st Annual Meeting

This new catheter, the first product commercialized from this novel technology platform, is designed to enable access to the blood vessels in the brain for both femoral and radial access. A multi-center analysis of this disruptive technology is being presented today at Society of NeuroInterventional Surgery 21st annual meeting. In addition, the Company confirmed the closing of a $20 million financing round led by NeuroTechnology Investors, which will be used to scale the company and expand the Radical platform notes Radical Catheter Technologies.

Rapid Medical™ Completes Initial Neurovascular Cases in the USA Following FDA Clearance of Its Active Access Solution

“With DRIVEWIRE, our design goal was to bring new levels of access and control to the interventional suite while improving best-in-class guidewires,” comments Giora Kornblau, Chief Technology Officer at Rapid Medical. “When physicians are looking for technologies that increase the clinical possibilities and safety for the patient, we want Rapid to be the first place they look.”